CD274 and sarcoma: First of all, it is essential to emphasise that the clinical predictive value of PD-L1 protein expression assessed on tumour samples has not been widely investigated in sarcoma patients and there is currently only scanty evidence from single-arm phase 2 studies of response to PD-L1 inhibitors.